The chemical class known as PRAME like-7 Activators encompasses a group of diverse compounds that interact with cellular processes to modulate gene expression, particularly through epigenetic mechanisms and signal transduction pathways. These activators target a range of molecular functions that include the modification of DNA methylation and histone acetylation, key processes that regulate chromatin structure and gene expression. When DNA methylation is inhibited, for instance, genes that are typically silenced can become active, leading to changes in cellular behavior. Histone acetylation, conversely, alters the chromatin landscape, making it more accessible for transcriptional machinery and thereby facilitating increased gene expression. These mechanisms of action are fundamental for altering the expression patterns of genes within the cell and can result in the upregulation of genes like PRAME like-7.
Activators within this class also encompass inhibitors of signaling pathways that indirectly lead to gene activation. By inhibiting specific pathways, such as NF-kB, these compounds can lead to changes in gene expression that counteract the repressive effects that these pathways may have. The alteration of signal transduction cascades can result in the stabilization and activation of transcription factors or other proteins that regulate gene expression, including those that may control the expression of PRAME like-7. Through these broad-ranging actions on epigenetic regulation and signal transduction, the PRAME like-7 Activators class can induce an environment conducive to the expression of PRAME like-7, thereby increasing its levels within the cell. This modulation of gene expression is crucial for the maintenance of cellular homeostasis and can have significant implications for the functioning of cells and the expression of genes involved in various cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that reduces DNA methylation, which could possibly activate silenced genes including PRAME like-7. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that increases histone acetylation, potentially promoting a more transcriptionally active chromatin state that could possibly activate PRAME like-7 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that also modulates epigenetic marks, which could possibly enhance the expression of genes like PRAME like-7 by altering signaling pathways. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor that can lead to hyperacetylation of histones and could possibly increase PRAME like-7 expression by creating a more open chromatin structure. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Aldehyde dehydrogenase inhibitor that can also inhibit the proteasome, possibly leading to the accumulation of regulatory proteins that could possibly activate PRAME like-7 expression. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
An NF-kB pathway inhibitor that can modulate immune responses and cellular stress pathways, possibly resulting in the upregulation of PRAME like-7. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that can affect a broad range of genes and could possibly upregulate PRAME like-7 through enhanced histone acetylation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Another HDAC inhibitor that can alter gene expression and could possibly increase PRAME like-7 levels by changing chromatin accessibility. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can facilitate chromatin remodeling and could possibly increase the transcription of PRAME like-7. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
An HDAC inhibitor that can modulate chromatin structure, potentially affecting the expression of genes including PRAME like-7. | ||||||